4.6 Article

Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma

Journal

BONE
Volume 50, Issue 1, Pages 171-181

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.bone.2011.10.012

Keywords

Bone neoplasm; cMYC; Osteosarcoma; miR-17-92; 14q32 miRNAs

Funding

  1. National Cancer Institute [P30 CA077598]
  2. University of Minnesota Academic Health Center
  3. Masonic Cancer Center, University of Minnesota
  4. Wyckoff Rein Foundations
  5. Van Sloun Foundations
  6. AKC Canine Health Foundation [2254, 947]
  7. NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Osteosarcoma (OS) is the common histological form of primary bone cancer and one of the leading aggressive cancers in children under age fifteen. Although several genetic predisposing conditions have been associated with OS the understanding of its molecular etiology is limited. Here, we show that microRNAs (miRNAs) at the chr.14q32 locus are significantly downregulated in osteosarcoma compared to normal bone tissues. Bioinformatic predictions identified that a subset of 14q32 miRNAs (miR-382, miR-369-3p, miR-544 and miR-134) could potentially target cMYC transcript. The physical interaction between these 14q32 miRNAs and cMYC was validated using reporter assays. Further, restoring expression of these four 14q32 miRNAs decreased cMYC levels and induced apoptosis in Saos2 cells. We also show that exogenous expression of 14q32 miRNAs in Saos2 cells significantly downregulated miR-17-92, a transcriptional target of cMYC. The pro-apoptotic effect of 14q32 miRNAs in Saos2 cells was rescued either by overexpression of cMYC cDNA without the 3'UTR or with miR-17-92 cluster. Further, array comparative genomic hybridization studies showed no DNA copy number changes at 14q32 locus in OS patient samples suggesting that downregulation of 14q32 miRNAs are not due to deletion at this locus. Together, our data support a model where the deregulation of a network involving 14q32 miRNAs, cMYC and miR-17-92 miRNAs could contribute to osteosarcoma pathogenesis. (C) 2011 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available